Nation-wide Hepatitis C Virus (HCV) Registry in Taiwan

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorKaohsiung Medical University Chung-Ho Memorial Hospital

About this trial

To determine the treatment efficacy, safety and long-term outcomes of chronic hepatitis C patients receiving directly acting antivirals in Taiwan

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

  • directly acting antivirals (DAAs)

Treatment groups

No treatment groups listed